You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ESR1 mutation

Showing 1 - 25 of 8,079
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer Trial (Lasofoxifene in combination with abemaciclib, Fulvestrant in combination with abemaciclib)

Not yet recruiting
  • Metastatic Breast Cancer
  • Lasofoxifene in combination with abemaciclib
  • Fulvestrant in combination with abemaciclib
  • (no location specified)
Jan 25, 2023

Hormone Receptor Positive Breast Carcinoma, Breast Tumors, Tumors, Breast Trial in Italy (Liquid biopsy and CT scan)

Recruiting
  • Hormone Receptor Positive Breast Carcinoma
  • +6 more
  • Liquid biopsy and CT scan
  • Bergame, Bergamo, Italy
  • +6 more
Apr 13, 2023

Metastatic Breast Cancer Trial in Pittsburgh (Fulvestrant, Tamoxifen, Palbociclib)

Active, not recruiting
  • Metastatic Breast Cancer
  • Pittsburgh, Pennsylvania
    Magee-Womens Hospital UPMC
Jul 22, 2021

Locally Advanced or Metastatic Breast Cancer Trial in Canada, Israel, United States (Lasofoxifene, Fulvestrant)

Active, not recruiting
  • Locally Advanced or Metastatic Breast Cancer
  • Phoenix, Arizona
  • +50 more
Oct 24, 2022

ER-Positive HER2-Negative Breast Cancer Trial in Worldwide (AZD9833, AZD9833 Placebo, Anastrozole)

Recruiting
  • ER-Positive HER2-Negative Breast Cancer
  • Phoenix, Arizona
  • +215 more
Aug 4, 2022

AXIN1 Gene Mutation, APC Gene Mutation, Solid Tumor Trial (REC-4881)

Not yet recruiting
  • AXIN1 Gene Mutation
  • +2 more
  • (no location specified)
Aug 21, 2023

Aumolertinib, Anlotinib, TP53 Trial (Aumolertinib,Anlotinib)

Not yet recruiting
  • Aumolertinib
  • +4 more
  • (no location specified)
Mar 8, 2023

Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 Mutation

Not yet recruiting
  • Autosomal Dominant Optic Atrophy
  • +3 more
    • Sydney, Australia
      Sydney Eye Hospital
    Nov 15, 2023

    Gene Mutation Trial in Beijing (RAG-17)

    Enrolling by invitation
    • Gene Mutation
    • Beijing, China
      Beijing Tiantan Hospital
    Jun 11, 2023

    ESR1 Mutations in Asian ER+ Metastatic Breast Cancer on Hormonal

    Unknown status
    • Metastatic Breast Cancer
    • Hormonal therapy-based treatments
    • Taipei, Taiwan
    • +1 more
    Jan 11, 2021

    An Intervention to Increase Genetic Testing in Families Who May

    Recruiting
    • BRCA1 Mutation
    • +21 more
    • Intervention Arm At-risk Relative/ARR Contacts
    • +5 more
    • Basking Ridge, New Jersey
    • +7 more
    Nov 22, 2022

    Solid Tumor, ARID1A Gene Mutation Trial in Greenville (Tazemetostat)

    Suspended
    • Solid Tumor
    • ARID1A Gene Mutation
    • Greenville, South Carolina
      Prisma Health Cancer Institute
    Jan 10, 2023

    Metastatic Solid Tumor, SF3B1 Gene Mutation, Spliceosome Mutation Trial in Baltimore (Recommendation for treatment with

    Recruiting
    • Metastatic Solid Tumor
    • +4 more
    • Recommendation for treatment with immunotherapy
    • Baltimore, Maryland
      Johns Hopkins University
    Sep 8, 2022

    Cholangiocarcinoma Non-resectable, Cholangiocarcinoma Metastatic Trial (Ivosidenib)

    Not yet recruiting
    • Cholangiocarcinoma Non-resectable
    • Cholangiocarcinoma Metastatic
    • (no location specified)
    Oct 10, 2023

    Non Small Cell Lung Cancer, Immune Checkpoint Inhibitor, EGFR Exon 21 Mutation Trial in Peking (Pembrolizumab, pemetrexed,

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • +2 more
    • Peking, China
      Peking Union Medical College Hospital
    Nov 16, 2023

    Breast Cancer Trial in Taipei (18F-FES PET)

    Unknown status
    • Breast Cancer
    • 18F-FES PET
    • Taipei, Taiwan
      National Taiwan Univeristy Hospital
    May 29, 2019

    Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression = 1% and an STK11

    Recruiting
    • Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation
    • Montpellier, France
    • +7 more
    Dec 19, 2022

    NSCLC Metastatic Trial in Stockholm (Stereotactic body radiation therapy (SBRT), Temporary Stopping)

    Recruiting
    • Non-small Cell Lung Cancer Metastatic
    • Stereotactic body radiation therapy (SBRT)
    • Temporary Stopping
    • Stockholm, Solna, Sweden
      Karolinska University Hospital
    Nov 9, 2023

    Retinal Dystrophy, PRPF31 Mutationassociated Retinal Dystrophy, RP11 Trial in Dallas (VP-001)

    Recruiting
    • Retinal Dystrophy
    • +2 more
    • Dallas, Texas
      Retina Foundation of the Southwest
    Jun 5, 2023

    Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +9 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 25, 2022

    Breast Cancer, Genetic Predisposition Trial in Rome, Varese (Genetic predisposition to breast cancer)

    Recruiting
    • Breast Cancer
    • Genetic Predisposition
    • Genetic predisposition to breast cancer
    • Rome, Italy
    • +1 more
    May 4, 2023

    BRCA1/2 Flu Vaccine

    Active, not recruiting
    • BRCA1 Mutation
    • BRCA2 Mutation
    • Seasonal influenza vaccine
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Aug 16, 2022

    BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

    Active, not recruiting
    Has Results
    • BRCA1 Gene Mutation
    • +5 more
    • Durvalumab
    • +3 more
    • Buffalo, New York
    • +1 more
    Jan 20, 2023

    Breast Cancer Trial in France (next-generation sequencing (NGS))

    Active, not recruiting
    • Breast Cancer
    • next-generation sequencing (NGS)
    • Metz, France
    • +9 more
    Aug 25, 2021

    Advanced Solid Tumors Trial (INCB099280, adagrasib)

    Not yet recruiting
    • Advanced Solid Tumors
    • (no location specified)
    Sep 8, 2023